This site is intended for healthcare professionals
Respiratory Syncytial Virus (RSV) in Adults Learning Zone

Managing RSV

Read time: 40 mins
Last updated:27th Oct 2021
Published:27th Oct 2021

Currently, treatment of respiratory syncytial virus (RSV) is limited to symptomatic management, and off-label use of the antiviral ribavirin. While a prophylactic treatment is available for paediatric populations at high risk of severe RSV, no preventative therapies are available for adults. Discover:

  • Limitations of current options and how to overcome these
  • Investigational vaccines in adult populations
  • Developments in antiviral treatments

Unmet needs for managing RSV

There is no approved treatment for respiratory syncytial virus (RSV), and preventative therapies are limited to infants and children at high risk of severe RSV infections1.

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

RSV prevention in adults

As there are no preventative treatments for adults at risk of severe respiratory syncytial virus (RSV), ongoing vaccine trials may be of interest to clinicians involved in managing the burden of RSV2.

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Treating RSV infections

Treatment goals for respiratory syncytial virus (RSV) are to relieve symptoms, reduce the time until symptoms are resolved, reduce viral load and limit transmission2.

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Welcome: